Subarachnoid aneurysm endovascular cohort study in China (SANE)

Conditions

Intracranial aneurysm

Aihua Liu, ShanShan Mi, Wang Bing, YongHong Duan, AiHua Liu

Stroke Vascular and Interventional Neurology2026-09-03

10.1161/svin.126.002556

Development and validation of the FLATS score to predict periprocedural ischemic events after stent-assisted coiling for ruptured intracranial aneurysms in the acute phase: a nationwide chinese registry.

Huang C, Zhong H, Bi Y, Zhong W, Wen Z, Chen Y, Duan C, Zhang Y, Huang M, Li Z, Chen W, Dai L, Ouyang Y, Huang J, Su S, Zhang X, Guo Z, Liang S, Li J, Wen C, Zhang X, Feng X, Li X, Gong S, Liu A, Duan C.

2026-07-15

10.1007/s10143-026-04396-6

Interventions

Stent only group:Simple stent placement

Coiling group:Coil embolism

Stent-assisted coiling group:Stent-assisted coiling

Balloon-assisted group:Balloon-assisted coiling

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. SAH clearly diagnosed by CT or lumbar puncture within 28 days after onset. 2. Subjects aged between 18 and 75 years old. 3. Intracranial aneurysms confirmed by the DSA, which are responsible lesions leading to this SAH. 4. Subjects who received endovascular treatment. 5. For multiple aneurysms, the treatment interval should be at least 6 months regardless of the previous treatment. 6. Subjects or their family agree to sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Subjects who received neurosurgical clipping. 2. RIA already treated. 3. Subjects who have major operations planned within 30 days of inclusion or 90 days after inclusion. 4. Subjects who have already participated in other clinical trials of drugs or medical devices before enrollment and have not reached their time limits. 5. Disabled before SAH, which might affect clinical outcomes one year after the operation. 6. Subjects who have malignant tumors. 7. Subjects with severe mental illness who are unable to communicate. 8. Subjects with poor systematic conditions who have a life expectancy of less than one year.

Design outcomes

Primary

Measure	Time frame
mRS score of 12 months after procedure;Ischemic complications;Hemorrhagic complications;Imaging prognosis;Long-term outcome;	—

Countries

China

Contacts

Public ContactAihua Liu, Youxiang Li

Beijing Tiantan Hospital, Capital Medical University

15901398688@163.com+86 15901398688

Outcome results

None listed